You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

proptosis

Showing 1 - 25 of 85
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thyroid Eye Disease, Graves Orbitopathy, Endocrine System Diseases Trial in Miami, Morgantown (linsitinib)

Recruiting
  • Thyroid Eye Disease
  • +11 more
  • Miami, Florida
  • +1 more
Oct 31, 2023

Thyroid Eye Disease Trial (peri-levator betamethasone injection, peri-levator triamcinolone injection, peri-levator and

Not yet recruiting
  • Thyroid Eye Disease
  • peri-levator betamethasone injection
  • +3 more
  • (no location specified)
Jul 15, 2021

Sphenoorbital Meningioma Management.

Not yet recruiting
  • Brain Meningioma
    • (no location specified)
    Jan 13, 2021

    Thyroid Eye Disease Trial in Germany, Italy, United States (Teprotumumab)

    Completed
    Has Results
    • Thyroid Eye Disease
    • Teprotumumab
    • Beverly Hills, California
    • +12 more
    Dec 9, 2021

    Thyroid Eye Disease, Graves' Orbitopathy Trial in Germany, Italy, United States (Teprotumumab, Placebo)

    Completed
    Has Results
    • Thyroid Eye Disease
    • Graves' Orbitopathy
    • Teprotumumab
    • Placebo
    • Beverly Hills, California
    • +13 more
    Jan 31, 2022

    Thyroid Eye Disease, Graves Orbitopathy, Endocrine System Diseases Trial in Canada, United Kingdom, United States (Linsitinib,

    Recruiting
    • Thyroid Eye Disease
    • +11 more
    • Beverly Hills, California
    • +22 more
    Jan 30, 2023

    Active Moderate to Severe Graves' Orbitopathy Trial (SHR-1314)

    Not yet recruiting
    • Active Moderate to Severe Graves' Orbitopathy
    • (no location specified)
    May 23, 2022

    Carotid-Cavernous Sinus Fistula Trial in Sohag (Endovascular management of direct carotid-cavernous fistula)

    Recruiting
    • Carotid-Cavernous Sinus Fistula
    • Endovascular management of direct carotid-cavernous fistula
    • Sohag, Egypt
      Ahmad Tharwat
    Oct 13, 2023

    Thyroid Eye Disease Trial in Miami (TOUR006 - 20 MG, Placebo, TOUR006 - 50 MG)

    Recruiting
    • Thyroid Eye Disease
    • TOUR006 - 20 MG
    • +2 more
    • Miami, Florida
      Site - 0103
    Oct 11, 2023

    Thyroid Eye Disease Trial (Satralizumab, Placebo)

    Not yet recruiting
    • Thyroid Eye Disease
    • (no location specified)
    Oct 25, 2023

    Thyroid Eye Disease Trial (VRDN-001 10 mg/kg Drug:)

    Not yet recruiting
    • Thyroid Eye Disease
    • VRDN-001 10 mg/kg Drug:
    • (no location specified)
    Sep 7, 2023

    Thyroid Eye Disease Trial (Satralizumab, Placebo)

    Not yet recruiting
    • Thyroid Eye Disease
    • (no location specified)
    Aug 4, 2023

    Thyroid Eye Disease Trial in Shanghai (IBI311, )

    Recruiting
    • Thyroid Eye Disease
    • IBI311
    • placebo
    • Shanghai, Shanghai, China
      Shanghai Ninth People's Hospital, Shanghai JiaoTong University S
    Mar 20, 2023

    Thyroid Eye Disease, Graves Orbitopathy Trial in Germany (Secukinumab, Placebo)

    Recruiting
    • Thyroid Eye Disease
    • Graves Orbitopathy
    • Essen, Germany
    • +6 more
    Jul 14, 2022

    Thyroid Eye Disease Trial in Worldwide (Teprotumumab, Placebo)

    Recruiting
    • Thyroid Eye Disease
    • Los Angeles, California
    • +28 more
    Jan 19, 2023

    Thyroid Eye Disease, Chronic (Inactive) Thyroid Eye Disease Trial in United States (TEPEZZA, Placebo)

    Active, not recruiting
    • Thyroid Eye Disease
    • Chronic (Inactive) Thyroid Eye Disease
    • TEPEZZA
    • Placebo
    • Beverly Hills, California
    • +11 more
    Nov 4, 2022

    Customized Multiple Orbital Wall Decompression for

    Recruiting
    • Thyroid Eye Disease
    • Modified multiple orbital wall decompression
    • Guangzhou, Guangdong, China
      Sun Yat-sen Memorial Hospital
    Nov 17, 2022

    Thyroid Eye Disease Trial in Beijing (ZB001 for injection)

    Not yet recruiting
    • Thyroid Eye Disease
    • ZB001 for injection
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Mar 7, 2023

    Thyroid Associated Orbitopathy Trial in Cairo (Methotrexate, Triamcinolone Acetonide)

    Completed
    • Thyroid Associated Orbitopathy
    • Cairo, Egypt
      Cairo University
    Jul 15, 2022

    Thyroid Ophthalmopathy Trial in Shanghai (HBM9161 680 mg qw by q2w from week 13, Placebo, HBM9161 680 mg qw by q2w from week 7)

    Recruiting
    • Thyroid Ophthalmopathy
    • HBM9161 680 mg qw by q2w from week 13
    • +2 more
    • Shanghai, Shanghai, China
      Shanghai Ninth People's Hospital, Shanghai Jiaotong University S
    Feb 22, 2022

    Thyroid Eye Disease Trial in United States (VRDN-001, Placebo)

    Recruiting
    • Thyroid Eye Disease
    • Beverly Hills, California
    • +16 more
    Aug 11, 2022

    Eye Diseases Trial in Damieta (Transcutaneous levator recession)

    Completed
    • Eye Diseases
    • Transcutaneous levator recession
    • Damieta, New Damietta, Egypt
      Ehab tharwat
    Jan 1, 2023

    Graves Ophthalmopathy Trial in Sofia (Methylprednisolone)

    Completed
    • Graves Ophthalmopathy
    • Sofia, Bulgaria
      University Hospital of Endocrinology
    Mar 29, 2023

    Graves' Ophthalmopathy Trial in Canada (RVT-1401)

    Completed
    Has Results
    • Graves' Ophthalmopathy
    • Vancouver, British Columbia, Canada
    • +3 more
    Dec 24, 2021

    Graves' Ophthalmopathy (GO) Trial in Worldwide (RVT-1401 (Administered via subcutaneous injection), Placebo (Administered via

    Terminated
    Has Results
    • Graves' Ophthalmopathy (GO)
    • RVT-1401 (Administered via subcutaneous injection)
    • Placebo (Administered via subcutaneous injection)
    • Beverly Hills, California
    • +24 more
    Aug 26, 2022